Linguistic and cultural adaptation of remote medication dispensing system (hub+spoke) for OUD treatment among limited english proficient (LEP) populations - the opioid epidemic is an urgent public…
Active Project Grant Awarded Last action
- Award ID
- R43MD021464
- Recipient
-
Opio Connect, Inc. UEI ULBXEK8CR7U1
- Awarding agency
-
National Institute for Minority Health and Health Disparities
National Institutes of Health, Department of Health and Human Services
- Obligated
- $356,648
Award facts
- Assistance listing
- 93.307 Minority Health and Health Disparities Research
- Completion date 21% complete
- Place of performance
- Kalispell, MT 59901, USA
Award details come from USAspending.gov.
About this award
The National Institute for Minority Health and Health Disparities awarded $356,648 to Opio Connect, Inc. on August 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307).
Opio Connect will linguistically and culturally adapt its ZING Satellite System—a remote medication dispensing platform that combines telehealth with robotic methadone preparation to expand opioid treatment program (OTP) access—for limited English proficient (LEP) patients. The Phase I Small Business Innovation Research project addresses treatment engagement gaps among LEP populations seeking opioid use disorder (OUD) care. Work comprises three specific aims: conducting structured interviews and community feedback sessions with two healthcare partner organizations serving LEP patients to identify language access and engagement priorities; adapting the ZING Satellite System to support multilingual user interfaces, AI-powered live translated captioning, and language-adapted workflows and instructional materials; and evaluating feasibility and usability through scenario-based testing and implementation feedback with LEP patients and clinical staff. The project employs a community-based participatory research approach with iterative stakeholder engagement and mixed-methods data collection.
Performance occurs in Kalispell, Montana, with work completing July 30, 2027.
Description
Linguistic and cultural adaptation of remote medication dispensing system (hub+spoke) for OUD treatment among limited english proficient (LEP) populations - the opioid epidemic is an urgent public health crisis in the united states: despite this, access to treatment for opioid use disorder (OUD) remains limited. Among patients seeking OUD treatment, those with limited english proficiency (LEP) show lower rates of treatment engagement, largely due to unmet language access needs in existing care delivery systems. The long-term objective of this project is to adapt opio's zing satellite™ system-which expands moud delivery through satellite medication units-to function effectively for LEP patients through a multilingual implementation model. Zing satellite combines telehealth with robotic methadone dose preparation to enable opioid treatment program (OTP) nurses to serve patients at satellite medication units. This phase i sbir project will focus on three specific aims: (1) identify language access and patient engagement priorities for LEP patients through structured interviews and community feedback sessions with two healthcare partner organizations serving LEP patients; (2) adapt the zing satellite system to support multilingual user interfaces, AI-powered live translated captioning, and language-adapted workflows and instructional materials; and (3) evaluate the feasibility and usability of the adapted system with LEP patients and clinical staff using scenario-based testing and structured implementation feedback. The project will use a community-based participatory research (cbpr) approach grounded in iterative stakeholder engagement, mixed-methods data collection, and external research support. This study improves the linguistic accessibility and usability of OUD treatment for LEP patients in a sustainable and scalable fashion. The findings will be relevant for digital health developers, addiction treatment providers, and policymakers seeking to improve medications for opioid use disorder (moud) access, and will offer a scalable model for adapting healthcare technologies-combining hardware and software solutions-to better serve patients with limited english proficiency across a range of clinical contexts.
Quick answers
Who received award R43MD021464?
R43MD021464 was awarded to Opio Connect, Inc. by National Institute for Minority Health and Health Disparities (National Institutes of Health) on August 5, 2026.
How much is award R43MD021464 worth?
$356,648 has been obligated on R43MD021464.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award